Compare BLCO & STAG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BLCO | STAG |
|---|---|---|
| Founded | 1853 | 2010 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Ophthalmic Goods | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.1B | 7.1B |
| IPO Year | 2022 | 2010 |
| Metric | BLCO | STAG |
|---|---|---|
| Price | $17.41 | $36.54 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 15 | 12 |
| Target Price | $19.39 | ★ $41.33 |
| AVG Volume (30 Days) | 485.4K | ★ 1.4M |
| Earning Date | 10-28-2026 | 10-27-2026 |
| Dividend Yield | N/A | ★ 4.27% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $5,101,000,000.00 | $845,184,000.00 |
| Revenue This Year | $7.68 | $7.47 |
| Revenue Next Year | $5.95 | $6.68 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | 6.47 | ★ 10.14 |
| 52 Week Low | $14.44 | $35.14 |
| 52 Week High | $18.92 | $42.61 |
| Indicator | BLCO | STAG |
|---|---|---|
| Relative Strength Index (RSI) | 56.37 | 51.08 |
| Support Level | $16.71 | $35.38 |
| Resistance Level | $17.54 | $36.89 |
| Average True Range (ATR) | 0.52 | 0.65 |
| MACD | 0.09 | 0.11 |
| Stochastic Oscillator | 93.60 | 77.43 |
Bausch & Lomb is one of the largest vision care companies in the US. The firm was previously a subsidiary under parent company Bausch Health and it was spun off to become a public company in 2022. It operates in three segments: vision care, surgical, and ophthalmic pharmaceuticals. Vision care is composed of contact lenses, a market that B&L controls 10%, and ocular health products, which includes Biotrue and Lumify. Surgical includes a suite of intraocular lenses, equipment for cataract and vitreoretinal surgeries, as well as surgical instruments. Ophthalmic pharmaceuticals has a diverse lineup of products, including Xipere, Vyzulta, and Lotemax that treat different complications. With over 100 products, B&L has the largest portfolio of eye care prescriptions in the space.
Stag Industrial Inc is a REIT focused on the acquisition, ownership, development, and operation of industrial properties throughout the United States. Its platform is designed to (i) identify properties for acquisition that offer attractive returns across CBRE-EA Tier 1 industrial real estate markets, industries, and tenants, (ii) provide growth through the ownership of high-quality assets, property management and pursuit of acquisitions in an attractive opportunity set, and (iii) capitalize its business appropriately given the characteristics of its assets. The majority of its portfolio is single-tenant industrial properties throughout the United States. The company derives the majority of its rental revenue from its facilities located in Midwestern and Eastern U.S. cities.